{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:27:25Z","timestamp":1791116845711,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T00:00:00Z","timestamp":1279670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T00:00:00Z","timestamp":1279670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2010,9,1]]},"DOI":"10.1002\/emmm.201000084","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T08:44:15Z","timestamp":1279701855000},"page":"349-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease"],"prefix":"10.1038","volume":"2","author":[{"given":"Stephen J.","family":"McConoughey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya V.","family":"Niatsetskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama F.","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett C.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lata","family":"Mahishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J. L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Antonyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick A.","family":"Cerione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Starkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish Kumar","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siiri E.","family":"Iismaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Pallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lawrence","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv R.","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,21]]},"reference":[{"key":"BFEMMM201000084_CR1","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","volume":"102","author":"N Agrawal","year":"2005","unstructured":"Agrawal N, Pallos J, Slepko N, Apostol BL, Bodai L, Chang LW, Chiang AS, Thompson LM, Marsh JL (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc Natl Acad Sci USA 102: 3777\u20103781","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR2","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.1074\/jbc.M112259200","volume":"277","author":"MA Antonyak","year":"2002","unstructured":"Antonyak MA, Boehm JE, Cerione RA (2002) Phosphoinositide 3\u2010kinase activity is required for retinoic acid\u2010induced expression and activation of the tissue transglutaminase. J Biol Chem 277: 14712\u201014716","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neurobiolaging.2005.04.001","volume":"27","author":"CD Bailey","year":"2006","unstructured":"Bailey CD, Johnson GV (2006) The protective effects of cystamine in the R6\/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase. Neurobiol Aging 27: 871\u2010879","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201000084_CR4","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1021\/bi9626620","volume":"36","author":"E Ballestar","year":"1997","unstructured":"Ballestar E, Franco L (1997) Use of the transglutaminase reaction to study the dissociation of histone N\u2010terminal tails from DNA in nucleosome core particles. Biochemistry 36: 5963\u20105969","journal-title":"Biochemistry"},{"key":"BFEMMM201000084_CR5","doi-asserted-by":"crossref","first-page":"18817","DOI":"10.1074\/jbc.271.31.18817","volume":"271","author":"E Ballestar","year":"1996","unstructured":"Ballestar E, Abad C, Franco L (1996) Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 271: 18817\u201018824","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR6","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/bi001575b","volume":"40","author":"E Ballestar","year":"2001","unstructured":"Ballestar E, Boix\u2010Chornet M, Franco L (2001) Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of ionic strength. Biochemistry 40: 1922\u20101929","journal-title":"Biochemistry"},{"key":"BFEMMM201000084_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-4159.2006.04140.x","volume":"100","author":"G Battaglia","year":"2007","unstructured":"Battaglia G, Farrace MG, Mastroberardino PG, Viti I, Fimia GM, Van Beeumen J, Devreese B, Melino G, Molinaro G, Busceti CL et al (2007) Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J Neurochem 100: 36\u201049","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR8","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3\u2010nitropropionic acid. J Neurosci 13: 4181\u20104192","journal-title":"J Neurosci"},{"key":"BFEMMM201000084_CR9","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn CL, Sun T, Sadri\u2010Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JH (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine\u2010dependent manner. J Neurosci 28: 10720\u201010733","journal-title":"J Neurosci"},{"key":"BFEMMM201000084_CR10","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1073\/pnas.78.9.5623","volume":"78","author":"HM Blau","year":"1981","unstructured":"Blau HM, Webster C (1981) Isolation and characterization of human muscle cells. Proc Natl Acad Sci USA 78: 5623\u20105627","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","volume":"116","author":"M Borrell\u2010Pages","year":"2006","unstructured":"Borrell\u2010Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P et al (2006) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116: 1410\u20101424","journal-title":"J Clin Invest"},{"key":"BFEMMM201000084_CR12","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age\u2010dependent neurological symptoms. Proc Natl Acad Sci USA 106: 22480\u201022485","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR13","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 285: 10653\u201010661","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR14","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan Jr.","year":"1985","unstructured":"Brennan WA, Jr., Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 44: 1948\u20101950","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147: 358\u2010382","journal-title":"Ann N Y Acad Sci"},{"key":"BFEMMM201000084_CR16","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 8: 2061\u20102073","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201000084_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41: 646\u2010653","journal-title":"Ann Neurol"},{"key":"BFEMMM201000084_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7","volume":"53","author":"E Cattaneo","year":"1998","unstructured":"Cattaneo E, Conti L (1998) Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res 53: 223\u2010234","journal-title":"J Neurosci Res"},{"key":"BFEMMM201000084_CR19","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M, Sassone J et al (2009) Impaired PGC\u20101alpha function in muscle in Huntington's disease. Hum Mol Genet 18: 3048\u20103065","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201000084_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2009-1387","volume":"95","author":"AO Chavez","year":"2010","unstructured":"Chavez AO, Kamath S, Jani R, Sharma LK, Monroy A, Abdul\u2010Ghani MA, Centonze VE, Sathyanarayana P, Coletta DK, Jenkinson CP et al (2010) Effect of short\u2010term free fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals. J Clin Endocrinol Metab 95: 422\u2010429","journal-title":"J Clin Endocrinol Metab"},{"key":"BFEMMM201000084_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","volume":"22","author":"AS Chen\u2010Plotkin","year":"2006","unstructured":"Chen\u2010Plotkin AS, Sadri\u2010Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP, Farrell LA, Krainc D, Gines S et al (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Disease 22: 233\u2010241","journal-title":"Neurobiol Disease"},{"key":"BFEMMM201000084_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1010791204961","volume":"33","author":"A Chomyn","year":"2001","unstructured":"Chomyn A (2001) Mitochondrial genetic control of assembly and function of complex I in mammalian cells. J Bioenerg Biomembr 33: 251\u2010257","journal-title":"J Bioenerg Biomembr"},{"key":"BFEMMM201000084_CR23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/314592a0","volume":"314","author":"A Chomyn","year":"1985","unstructured":"Chomyn A, Mariottini P, Cleeter MW, Ragan CI, Matsuno\u2010Yagi A, Hatefi Y, Doolittle RF, Attardi G (1985) Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory\u2010chain NADH dehydrogenase. Nature 314: 592\u2010597","journal-title":"Nature"},{"key":"BFEMMM201000084_CR24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1126\/science.3764430","volume":"234","author":"A Chomyn","year":"1986","unstructured":"Chomyn A, Cleeter MW, Ragan CI, Riley M, Doolittle RF, Attardi G (1986) URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science (New York, NY) 234: 614\u2010618","journal-title":"Science (New York, NY)"},{"key":"BFEMMM201000084_CR25","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","volume":"13","author":"A Ciammola","year":"2006","unstructured":"Ciammola A, Sassone J, Alberti L, Meola G, Mancinelli E, Russo MA, Squitieri F, Silani V (2006) Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects. Cell Death Differ 13: 2068\u20102078","journal-title":"Cell Death Differ"},{"key":"BFEMMM201000084_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","volume":"39","author":"P Conforti","year":"2008","unstructured":"Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E (2008) Blood level of brain\u2010derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP\u20101347. Mol Cell Neurosci 39: 1\u20107","journal-title":"Mol Cell Neurosci"},{"key":"BFEMMM201000084_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC\u20101alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59\u201069","journal-title":"Cell"},{"key":"BFEMMM201000084_CR28","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJ, Ratan RR, Beal MF et al (2002) Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci 22: 8942\u20108950","journal-title":"J Neurosci"},{"issue":"5576","key":"BFEMMM201000084_CR29","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, Krainc D (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science (New York, NY) 296(5576), 2238\u20102243","journal-title":"Science (New York, NY)"},{"key":"BFEMMM201000084_CR30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1471-4159.2007.04592.x","volume":"102","author":"D Fernandes","year":"2007","unstructured":"Fernandes D, Zaidi A, Bean J, Hui D, Michaelis ML (2007) RNA\u2010induced silencing of the plasma membrane Ca2+\u2010ATPase 2 in neuronal cells: effects on Ca2+ homeostasis and cell viability. J Neurochem 102: 454\u2010465","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0092-8674(95)90436-0","volume":"82","author":"U Fischer","year":"1995","unstructured":"Fischer U, Huber J, Boelens WC, Mattaj IW, Luhrmann R (1995) The HIV\u20101 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82: 475\u2010483","journal-title":"Cell"},{"key":"BFEMMM201000084_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(08)60217-X","volume":"31","author":"JE Folk","year":"1977","unstructured":"Folk JE, Finlayson JS (1977) The epsilon\u2010(gamma\u2010glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 31: 1\u2010133","journal-title":"Adv Protein Chem"},{"key":"BFEMMM201000084_CR33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","volume":"91","author":"JH Fox","year":"2004","unstructured":"Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A et al (2004) Cystamine increases L\u2010cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem 91: 413\u2010422","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z et al (2006) Cleavage at the caspase\u20106 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125: 1179\u20101191","journal-title":"Cell"},{"key":"BFEMMM201000084_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2010.01.001","volume":"37","author":"J Hageman","year":"2010","unstructured":"Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, Oosterveld\u2010Hut HM, Lubsen NH, Kampinga HH (2010) A DNAJB chaperone subfamily with HDAC\u2010dependent activities suppresses toxic protein aggregation. Mol Cell 37: 355\u2010369","journal-title":"Mol Cell"},{"key":"BFEMMM201000084_CR36","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","volume":"29","author":"MY Heng","year":"2009","unstructured":"Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL (2009) In vivo evidence for NMDA receptor\u2010mediated excitotoxicity in a murine genetic model of Huntington disease. J Neurosci 29: 3200\u20103205","journal-title":"J Neurosci"},{"key":"BFEMMM201000084_CR37","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1074\/jbc.275.17.13134","volume":"275","author":"RP Herzig","year":"2000","unstructured":"Herzig RP, Scacco S, Scarpulla RC (2000) Sequential serum\u2010dependent activation of CREB and NRF\u20101 leads to enhanced mitochondrial respiration through the induction of cytochrome c. J Biol Chem 275: 13134\u201013141","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR38","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/dvdy.21624","volume":"237","author":"J Ikle","year":"2008","unstructured":"Ikle J, Elwell JA, Bryantsev AL, Cripps RM (2008) Cardiac expression of the Drosophila transglutaminase (CG7356) gene is directly controlled by myocyte enhancer factor\u20102. Dev Dyn 237: 2090\u20102099","journal-title":"Dev Dyn"},{"key":"BFEMMM201000084_CR39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bcp.2004.12.011","volume":"69","author":"TM Jeitner","year":"2005","unstructured":"Jeitner TM, Delikatny EJ, Ahlqvist J, Capper H, Cooper AJ (2005) Mechanism for the inhibition of transglutaminase 2 by cystamine. Biochem Pharmacol 69: 961\u2010970","journal-title":"Biochem Pharmacol"},{"key":"BFEMMM201000084_CR40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2008.05350.x","volume":"106","author":"TM Jeitner","year":"2008","unstructured":"Jeitner TM, Matson WR, Folk JE, Blass JP, Cooper AJ (2008) Increased levels of gamma\u2010glutamylamines in Huntington disease CSF. J Neurochem 106: 37\u201044","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR41","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43: 2689\u20102695","journal-title":"Neurology"},{"key":"BFEMMM201000084_CR42","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.96.13.7388","volume":"96","author":"MV Karpuj","year":"1999","unstructured":"Karpuj MV, Garren H, Slunt H, Price DL, Gusella J, Becher MW, Steinman L (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc Natl Acad Sci USA 96: 7388\u20107393","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","volume":"8","author":"MV Karpuj","year":"2002","unstructured":"Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R, Mitchell D, Steinman L (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8: 143\u2010149","journal-title":"Nat Med"},{"key":"BFEMMM201000084_CR44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7: 854\u2010868","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM201000084_CR45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","volume":"60","author":"D Kim","year":"2008","unstructured":"Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P et al (2008) Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity. Neuron 60: 803\u2010817","journal-title":"Neuron"},{"key":"BFEMMM201000084_CR46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nm0110-32","volume":"16","author":"D Krainc","year":"2010","unstructured":"Krainc D 2010 Huntington's disease: tagged for clearance. Nat Med 16: 32\u201033","journal-title":"Nat Med"},{"key":"BFEMMM201000084_CR47","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","volume":"280","author":"J Lee","year":"2005","unstructured":"Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, Murphy AN, Lonze BE, Kim KS, Ginty DD et al (2005) Mitochondrial cyclic AMP response element\u2010binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem 280: 40398\u201040401","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR48","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","volume":"3","author":"JM Lee","year":"2007","unstructured":"Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I, Gusella JF, MacDonald ME (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra\u2010mitochondrial energy metabolism. PLoS Genet 3: e135","journal-title":"PLoS Genet"},{"key":"BFEMMM201000084_CR49","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1074\/jbc.273.20.11991","volume":"273","author":"M Lesort","year":"1998","unstructured":"Lesort M, Attanavanich K, Zhang J, Johnson GV (1998) Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 273: 11991\u201011994","journal-title":"J Biol Chem"},{"key":"BFEMMM201000084_CR50","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1046\/j.1471-4159.2000.0751951.x","volume":"75","author":"M Lesort","year":"2000","unstructured":"Lesort M, Tucholski J, Zhang J, Johnson GV (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J Neurochem 75: 1951\u20101961","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang H, Ward WF (2006) PGC\u20101alpha: a key regulator of energy metabolism. Adv Physiol Educ 30: 145\u2010151","journal-title":"Adv Physiol Educ"},{"key":"BFEMMM201000084_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","volume":"119","author":"J Lin","year":"2004","unstructured":"Lin J, Wu PH, Tarr PT, Lindenberg KS, St\u2010Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM et al (2004) Defects in adaptive energy metabolism with CNS\u2010linked hyperactivity in PGC\u20101alpha null mice. Cell 119: 121\u2010135","journal-title":"Cell"},{"key":"BFEMMM201000084_CR53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00240602","volume":"58","author":"L Lorand","year":"1984","unstructured":"Lorand L, Conrad SM (1984) Transglutaminases. Mol Cell Biochem 58: 9\u201035","journal-title":"Mol Cell Biochem"},{"key":"BFEMMM201000084_CR54","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2006.04686.x","volume":"23","author":"Z Mao","year":"2006","unstructured":"Mao Z, Choo YS, Lesort M (2006) Cystamine and cysteamine prevent 3\u2010NP\u2010induced mitochondrial depolarization of Huntington's disease knock\u2010in striatal cells. Eur J Neurosci 23: 1701\u20101710","journal-title":"Eur J Neurosci"},{"key":"BFEMMM201000084_CR55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuron.2006.09.025","volume":"52","author":"JL Marsh","year":"2006","unstructured":"Marsh JL, Thompson LM (2006) Drosophila in the study of neurodegenerative disease. Neuron 52: 169\u2010178","journal-title":"Neuron"},{"key":"BFEMMM201000084_CR56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","volume":"9","author":"PG Mastroberardino","year":"2002","unstructured":"Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L et al (2002) \u2018Tissue\u2019 transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9: 873\u2010880","journal-title":"Cell Death Differ"},{"key":"BFEMMM201000084_CR57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ab.2009.03.022","volume":"390","author":"SJ McConoughey","year":"2009","unstructured":"McConoughey SJ, Niatsetskaya ZV, Pasternack R, Hils M, Ratan RR, Cooper AJ (2009) A nonradioactive dot blot assay for transglutaminase activity. Anal Biochem 390: 91\u201093","journal-title":"Anal Biochem"},{"key":"BFEMMM201000084_CR58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR et al 2010 Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 65: 178\u2010190","journal-title":"Neuron"},{"key":"BFEMMM201000084_CR59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/ars.2009.2800","volume":"12","author":"Z Niatsetskaya","year":"2010","unstructured":"Niatsetskaya Z, Basso M, Speer RE, McConoughey SJ, Coppola G, Ma TC, Ratan RR 2010 HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. Antioxid Redox Signal 12: 435\u2010443","journal-title":"Antioxid Redox Signal"},{"key":"BFEMMM201000084_CR60","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A, Kaul M, Graham RK et al (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 15: 1407\u20101413","journal-title":"Nat Med"},{"key":"BFEMMM201000084_CR61","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1073\/pnas.87.21.8472","volume":"87","author":"KN Parameswaran","year":"1990","unstructured":"Parameswaran KN, Velasco PT, Wilson J, Lorand L (1990) Labeling of epsilon\u2010lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA 87: 8472\u20108475","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR62","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1051\/medsci\/2005215556","volume":"21","author":"AJ Parker","year":"2005","unstructured":"Parker AJ, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Med Sci (Paris) 21: 556\u2010557","journal-title":"Med Sci (Paris)"},{"key":"BFEMMM201000084_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(99)00018-6","volume":"446","author":"X Peng","year":"1999","unstructured":"Peng X, Zhang Y, Zhang H, Graner S, Williams JF, Levitt ML, Lokshin A (1999) Interaction of tissue transglutaminase with nuclear transport protein importin\u2010alpha3. FEBS Lett 446: 35\u201039","journal-title":"FEBS Lett"},{"key":"BFEMMM201000084_CR64","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","volume":"24","author":"A Petersen","year":"2006","unstructured":"Petersen A, Bjorkqvist M (2006) Hypothalamic\u2010endocrine aspects in Huntington's disease. Eur J Neurosci 24: 961\u2010967","journal-title":"Eur J Neurosci"},{"key":"BFEMMM201000084_CR65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Spiegelman BM (2003) Peroxisome proliferator\u2010activated receptor\u2010gamma coactivator 1 alpha (PGC\u20101 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78\u201090","journal-title":"Endocr Rev"},{"key":"BFEMMM201000084_CR66","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1474-4422(09)70276-5","volume":"8","author":"RR Ratan","year":"2009","unstructured":"Ratan RR (2009) Epigenetics and the nervous system: epiphenomenon or missing piece of the neurotherapeutic puzzle? Lancet Neurol 8: 975\u2010977","journal-title":"Lancet Neurol"},{"key":"BFEMMM201000084_CR67","doi-asserted-by":"crossref","first-page":"19599","DOI":"10.1073\/pnas.0907935106","volume":"106","author":"MA Rivieccio","year":"2009","unstructured":"Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K, Siddiq A, Kozikowski AP, Jaffrey SR, Twiss JL et al (2009) HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci USA 106: 19599\u201019604","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR68","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","volume":"13","author":"Q Ruan","year":"2004","unstructured":"Ruan Q, Lesort M, MacDonald ME, Johnson GV (2004) Striatal cells from mutant huntingtin knock\u2010in mice are selectively vulnerable to mitochondrial complex II inhibitor\u2010induced cell death through a non\u2010apoptotic pathway. Hum Mol Genet 13: 669\u2010681","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201000084_CR69","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","volume":"100","author":"H Ryu","year":"2003","unstructured":"Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan\u2010Clifford J, Ferrante RJ, Ratan RR (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1\u2010dependent pathway. Proc Natl Acad Sci USA 100: 4281\u20104286","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR70","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci USA 103: 19176\u201019181","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR71","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM, Myers RH, Lesort M et al (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14: 2871\u20102880","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201000084_CR72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/13543780902810345","volume":"18","author":"SF Sleiman","year":"2009","unstructured":"Sleiman SF, Basso M, Mahishi L, Kozikowski AP, Donohoe ME, Langley B, Ratan RR (2009) Putting the \u2018HAT\u2019 back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs 18: 573\u2010584","journal-title":"Expert Opin Investig Drugs"},{"key":"BFEMMM201000084_CR73","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Michaud J, Scott HS (2005) Use of within\u2010array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067\u20102075","journal-title":"Bioinformatics"},{"key":"BFEMMM201000084_CR74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/9780470725207.ch5","volume":"287","author":"BM Spiegelman","year":"2007","unstructured":"Spiegelman BM (2007) Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287: 60\u201063, discussion 63\u201369","journal-title":"Novartis Found Symp"},{"key":"BFEMMM201000084_CR75","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic\u2010Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington's disease protein interacts with p53 and CREB\u2010binding protein and represses transcription. Proc Natl Acad Sci USA 97: 6763\u20106768","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR76","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M et al (2001) Histone deacetylase inhibitors arrest polyglutamine\u2010dependent neurodegeneration in Drosophila. Nature 413: 739\u2010743","journal-title":"Nature"},{"key":"BFEMMM201000084_CR77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St\u2010Pierre","year":"2006","unstructured":"St\u2010Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC\u20101 transcriptional coactivators. Cell 127: 397\u2010408","journal-title":"Cell"},{"key":"BFEMMM201000084_CR78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45: 25\u201032","journal-title":"Ann Neurol"},{"key":"BFEMMM201000084_CR79","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1053\/j.gastro.2009.01.007","volume":"136","author":"H Tatsukawa","year":"2009","unstructured":"Tatsukawa H, Fukaya Y, Frampton G, Martinez\u2010Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J et al (2009) Role of transglutaminase 2 in liver injury via cross\u2010linking and silencing of transcription factor Sp1. Gastroenterology 136: 1783\u20101795, e1710","journal-title":"Gastroenterology"},{"key":"BFEMMM201000084_CR80","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E, Burnett R, Gao F, Fitzgerald KM, Borok JF, Herman D et al (2008) The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci USA 105: 15564\u201015569","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201000084_CR81","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch\u2010Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9: 2799\u20102809","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201000084_CR82","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","volume":"95","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Bailey CD, Rogers DA, Johnson GV, Hayden MR, Leavitt BR (2005) Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J Neurochem 95: 210\u2010220","journal-title":"J Neurochem"},{"key":"BFEMMM201000084_CR83","first-page":"1","volume":"109","author":"WM van Roon\u2010Mom","year":"2002","unstructured":"van Roon\u2010Mom WM, Reid SJ, Jones AL, MacDonald ME, Faull RL, Snell RG (2002) Insoluble TATA\u2010binding protein accumulation in Huntington's disease cortex. Brain Res 109: 1\u201010","journal-title":"Brain Res"},{"key":"BFEMMM201000084_CR84","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57: 369\u2010384","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201000084_CR85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnen\/64.1.58","volume":"64","author":"GM Zainelli","year":"2005","unstructured":"Zainelli GM, Dudek NL, Ross CA, Kim SY, Muma NA (2005) Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J Neuropathol Exp Neurol 64: 58\u201065","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201000084_CR86","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA (2002) Increased sensitivity to N\u2010methyl\u2010D\u2010aspartate receptor\u2010mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33: 849\u2010860","journal-title":"Neuron"},{"key":"BFEMMM201000084_CR87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain\u2010derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5: 311\u2010322","journal-title":"Nat Rev Neurol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201000084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emmm.201000084","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1002\/emmm.201000084\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1002\/emmm.201000084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201000084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:58:34Z","timestamp":1779083914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1002\/emmm.201000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,21]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9,1]]}},"alternative-id":["BFEMMM201000084"],"URL":"https:\/\/doi.org\/10.1002\/emmm.201000084","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,21]]},"assertion":[{"value":"4 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}